Less than three weeks away: Join Global Experts at Transdermal Microneedle Delivery Conference 2024 in London
SAE Media Group is delighted to announce the Transdermal Microneedle Delivery Conference 2024, taking place on 11-12 November 2024 in London, UK. This premier event will bring together world-leading experts and innovators from the pharmaceutical and medical sectors to explore the latest developments in microneedle technologies and their potential for transdermal drug delivery.
As the field of drug delivery continues to evolve, there is a growing demand for non-invasive, patient-friendly, and efficient delivery systems. The Transdermal Microneedle Delivery Conference 2024 will serve as a key platform for pharmaceutical companies, researchers, and healthcare professionals to share insights and strategies on the future of microneedle technologies, with the potential to revolutionise drug administration.
Time is running out to secure your spot — click here to reserve your tickets and join the innovators shaping the future of drug delivery!
Key highlights of the conference include:
- Cutting-edge Research: Explore how microneedle technology is being applied to enhance the delivery of vaccines, biologics, and small molecules in both research and clinical settings.
- Expert-Led Panels: Participate in discussions led by industry leaders, academic researchers, and medical professionals on the latest advancements in transdermal systems and their future applications.
- Interactive Networking Opportunities: Engage with fellow researchers, pharmaceutical executives, and technology innovators to foster collaborations that drive innovation in the field of microneedle delivery.
As healthcare increasingly embraces innovative delivery methods, the role of microneedles in improving patient outcomes and enhancing therapeutic efficiency has never been more critical. The Transdermal Microneedle Delivery Conference 2024 will address these developments, offering attendees unparalleled access to cutting-edge research and the latest innovations in this rapidly expanding field.
Mahmoud Ameri, Vice President, Emergex USA Corporation and conference chair, said, “The 2024 agenda will showcase the latest advances in transdermal drug delivery coupled with a new outlook on microneedle design. The conference will consider key developments in the transdermal drug delivery field, including the real-world applications of microneedle systems as a mode for vaccine delivery, the latest trends in transdermal drug delivery as a therapeutic tool, advances in microarray patches and microneedle-based diagnostics and a regulatory update on the transdermal and microneedle drug delivery field.”
For more information about the Transdermal Microneedle Delivery Conference 2024, please contact:
- Conference Producer: Yasmin Alasdoon at yasmin.alsadoon@saemediagroup.com
- Sponsorship & Exhibition Opportunities: Michael Fraser, Sponsorship Sales Manager at michael.fraser@saemediagroup.com
- Delegate Tickets: Abigail Owen, Business Development Executive at abigail.owen@saemediagroup.com
- Marketing Opportunities: Elliott Karmel, Senior Marketing Lead at elliott.karmel@saemediagroup.com
About SAE Media Group
SAE Media Group (www.smgconferences.com), based in London, organizes more than 45 high-level conferences across the globe, specializing in the Aerospace, Defence, Pharmaceutical, and Medical industries. These events bring together senior professionals from both government and industry to collaborate on key technological innovations, including drug delivery systems, microbiology, and advanced therapeutics.
